当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析 - 现金流量表

华恒生物

(688639)

  

流通市值:46.92亿  总市值:46.92亿
流通股本:2.50亿   总股本:2.50亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,510,101,855.13788,113,324.342,730,918,428.862,139,169,844.58
  收到的税费返还133,725,028.5522,940,184.9787,297,402.3778,172,268.57
  收到其他与经营活动有关的现金10,489,654.085,747,219.8452,650,507.0635,578,875.03
  经营活动现金流入小计1,654,316,537.76816,800,729.152,870,866,338.292,252,920,988.18
  购买商品、接受劳务支付的现金1,271,906,630.43661,444,327.192,186,529,162.151,717,363,072.23
  支付给职工以及为职工支付的现金188,198,561.15106,062,798.56321,639,985.93233,611,314.08
  支付的各项税费33,674,120.4210,568,728.7255,282,272.447,546,495.16
  支付其他与经营活动有关的现金86,132,002.2525,652,501.35202,868,246.72139,658,595.71
  经营活动现金流出小计1,579,911,314.25803,728,355.822,766,319,667.22,138,179,477.18
  经营活动产生的现金流量净额74,405,223.5113,072,373.33104,546,671.09114,741,511
二、投资活动产生的现金流量:
  收回投资收到的现金831,899.02---
  取得投资收益收到的现金1,800,000-900,000-
  处置固定资产、无形资产和其他长期资产收回的现金净额14,000-1,187,534.5137,856.7
  收到的其他与投资活动有关的现金6,625,000---
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计9,270,899.02-2,087,534.5137,856.7
  购建固定资产、无形资产和其他长期资产支付的现金276,257,379.62169,210,742.42636,725,336.47394,487,095.37
  投资支付的现金--2,816,500-
  支付其他与投资活动有关的现金5,665,0002,130,0006,001,566.5310,002,257.87
  投资活动现金流出小计281,922,379.62171,340,742.42645,543,403404,489,353.24
  投资活动产生的现金流量净额-272,651,480.6-171,340,742.42-643,455,868.49-404,451,496.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金--5,075,560.445,075,560.44
  取得借款收到的现金961,377,613.44667,003,401.881,717,908,246.631,453,017,760.95
  收到其他与筹资活动有关的现金65,090,344.33---
  筹资活动现金流入小计1,026,467,957.77667,003,401.881,722,983,807.071,458,093,321.39
  偿还债务支付的现金477,886,356.85326,528,555.71,186,918,259.96990,237,333.19
  分配股利、利润或偿付利息支付的现金71,191,264.5314,537,247.8110,813,237.66101,748,248.89
  支付其他与筹资活动有关的现金6,582,225.562,337,795.4616,032,937.34150,000
  筹资活动现金流出小计555,659,846.94343,403,598.961,313,764,434.961,092,135,582.08
  筹资活动产生的现金流量净额470,808,110.83323,599,802.92409,219,372.11365,957,739.31
四、汇率变动对现金及现金等价物的影响-6,978,731.47-3,274,039.73-1,147,319.181,745,348.3
五、现金及现金等价物净增加额265,583,122.27162,057,394.1-130,837,144.4777,993,102.07
  加:期初现金及现金等价物余额284,122,206.43284,122,206.43414,959,350.9414,959,350.9
  期末现金及现金等价物余额549,705,328.7446,179,600.53284,122,206.43492,952,452.97
补充资料:
  净利润87,674,653.84-123,861,236.18-
  资产减值准备5,155,592.62-13,732,484.87-
  固定资产和投资性房地产折旧145,058,912.25-209,157,496.81-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧145,058,912.25-209,157,496.81-
  无形资产摊销2,933,393.88-5,640,802.57-
  长期待摊费用摊销5,870,192.91-6,239,814.97-
  处置固定资产、无形资产和其他长期资产的损失15,766.35--122,573.32-
  固定资产报废损失2,981,097.15-1,861,198.12-
  公允价值变动损失219,832.95---
  财务费用32,753,544.41-42,685,129.98-
  投资损失-1,791,510.63-915,414.66-
  递延所得税-14,649,051.6--24,500,028.45-
  其中:递延所得税资产减少11,806,434.63--58,757,523.06-
    递延所得税负债增加-26,455,486.23-34,257,494.61-
  存货的减少-99,042,359.36--138,942,755.94-
  经营性应收项目的减少-68,010,010.16--73,479,827.55-
  经营性应付项目的增加-25,876,403.02--66,780,968.05-
  其他--3,881,707.55-
  现金的期末余额549,705,328.7-284,122,206.43-
  减:现金的期初余额284,122,206.43-414,959,350.9-
  现金及现金等价物的净增加额265,583,122.27--130,837,144.47-
公告日期2026-08-252026-04-232026-03-182025-10-28
审计意见(境内)标准无保留意见
TOP↑